Literature DB >> 22625221

Plasma glycation levels are associated with severity in sepsis.

Michael Éverton Andrades1, Rodrigo Lorenzi, Ryoji Nagai, José Cláudio Fonseca Moreira, Cristiane Ritter, Felipe Dal-Pizzol.   

Abstract

BACKGROUND: Advanced glycation end-products (AGE) have been involved in inflammatory diseases and may have an important role in the progression of symptoms. However, few studies have analysed the levels of glycated proteins in sepsis. In this study, we evaluated the levels of the well-known AGE (N(ε) -(carboxymethyl)lysine (CML) and N(ε) -(carboxyethyl)lysine (CEL)) in the plasma of septic patients.
MATERIAL AND METHODS: Plasma from 36 patients admitted to an adult intensive care unit and 6 healthy controls had the levels of CML/CEL measured by ELISA.
RESULTS: The level of AGE in plasma decreased with the increase of severity (1·40±0·46 nmol/mg of protein in sepsis, 0·58±0·23 nmol/mg of protein in severe sepsis and 0·31±0·12 nmol/mg of protein in septic shock). Control plasma presented low AGE concentration (0·06±0·01 nmol/mg protein). Also, we found a decrease in plasma AGE in those patients that died at the end of 28 days follow-up (0·80±0·50 nmol/mg of protein in survivors vs. 0·31±0·10 nmol/mg of protein in nonsurvivors), being associated with the renal component of sequential organ failure assessment (SOFA) score. In the same line, there was a decrease in plasma AGE with the increase in SOFA.
CONCLUSIONS: Our data demonstrate that plasma AGE levels are inversely associated with the severity of sepsis and may be associated with kidney dysfunction.
© 2012 The Authors. European Journal of Clinical Investigation © 2012 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22625221     DOI: 10.1111/j.1365-2362.2012.02694.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  3 in total

1.  Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.

Authors:  Carl I Schulman; Jaime Uribarri; Weijing Cai; Ron Manning; David C Landy; Margaret Gallardo; Angela Castillo; Nicholas Namias; Gary E Striker; Alan Livingstone; Helen Vlassara
Journal:  Clin Chem Lab Med       Date:  2014-01-01       Impact factor: 3.694

2.  The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.

Authors:  John H Meertens; Hans L Nienhuis; Joop D Lefrandt; Casper G Schalkwijk; Kristiina Nyyssönen; Jack J M Ligtenberg; Andries J Smit; Jan G Zijlstra; D J Mulder
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

3.  Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis.

Authors:  Zhengzheng Yan; Haihua Luo; Bingyao Xie; Tian Tian; Shan Li; Zhixia Chen; Jinghua Liu; Xuwen Zhao; Liyong Zhang; Yongqiang Deng; Timothy R Billiar; Yong Jiang
Journal:  Nat Commun       Date:  2021-01-12       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.